openPR Logo
Press release

PetVivo (OTCQB: PETV) Revolutionizes Veterinary Medicine, Boosts Revenue, New Leadership! see more stocks inside....

10-01-2024 11:56 PM CET | Energy & Environment

Press release from: ABNewswire

PetVivo (OTCQB: PETV) Revolutionizes Veterinary Medicine,

PetVivo Holdings, Inc. (OTCQB: PETV), a biomedical device company focused on innovative solutions for companion animals, is driving revenue growth by transforming veterinary care. The recent appointment of industry expert Mike Eldred to its Board of Directors strengthens its position. Eldred, a former CEO of North American Operations at Dechra Pharmaceuticals, brings a wealth of experience in scaling businesses and boosting sales. Under his leadership, Dechra's sales reached 191.6 million, and his strategic expertise will help PetVivo expand its market presence.

Image: https://www.abnewswire.com/uploads/4356aec75979a0698162afac93844cf0.jpg

PetVivo's flagship product, Spryng Trademark with OsteoCushion Trademark Technology, is an injectable treatment for joint-related conditions like osteoarthritis in pets. By adapting human therapies for veterinary use, the company accelerates market entry and revenue generation. With a portfolio of 21 patents, PetVivo is well-positioned to lead in innovative animal healthcare solutions while enhancing its profitability.

"Mike's expertise aligns with our goal of revolutionizing veterinary medicine and driving growth," said John Lai, CEO of PetVivo.

PetVivo Holdings, Inc. creates innovative medical devices for companion animals, with a focus on accelerating the market launch of therapies adapted from human treatments. Its flagship product, Spryng with OsteoCushion Technology, along with a robust portfolio of 21 patents, positions the company for strong revenue growth and leadership in animal healthcare solutions. For more information, visit petvivo.com [http://www.petvivo.com/].

Here are five additional companies under $1 demonstrating robust market trends, volume, and awareness:

AgEagle Aerial Systems Inc. (NYSE: UAVS) pioneers advanced drone solutions for agriculture and delivery.

Bitech Technologies (OTCQB: BTTC) focuses on renewable energy innovations.

Silexion Therapeutics Corp. (NASDAQ: SLXN) advances groundbreaking biotech therapies.

1606 Corp. (OTC: CBDW) AI-powered healthcare "Adnexus", an AI-driven drug discovery leader

MicroCloud Hologram Inc. (NASDAQ: HOLO) drives cutting-edge holographic technologies.

These companies are actively leveraging technology in their respective sectors, showcasing market strength through their innovative products and services.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=petvivo-otcqb-petv-revolutionizes-veterinary-medicine-boosts-revenue-new-leadership-see-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PetVivo (OTCQB: PETV) Revolutionizes Veterinary Medicine, Boosts Revenue, New Leadership! see more stocks inside.... here

News-ID: 3675032 • Views:

More Releases from ABNewswire

Dry Eye Disease Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Palatin Technologies, Novaliq, mc2 therapeutics
Dry Eye Disease Market Growth to Accelerate in Forecast Period (2024-2034), Delv …
The Key Dry Eye Disease Companies in the market include - Palatin Technologies, Novaliq, mc2 therapeutics, and others. The Dry Eye Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye Disease market dynamics. DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding
Atopic Dermatitis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharma, SCM Lifescience, Sun Pharma, Brickell Bio
Atopic Dermatitis Market Forecasted to Surge in Coming Years, 2024-2034 Analysis …
The Key Atopic Dermatitis Companies in the market include - Kymab, BiomX, LEO Pharma, GlaxoSmithKline, Arjil Pharmaceuticals, SCM Lifescience, Sun Pharmaceutical Industries Limited, Brickell Biotech Inc,, AstraZeneca, Kyowa Kirin, UCB Biopharma, Arcutis Biotherapeutics, Vanda Pharmaceuticals, Kyowa Kirin, Sanofi, KeyMed Biosciences, Asana BioSciences, Bristol-Myers Squibb, RAPT Therapeutics, Allakos, Novartis, BioMimetix, Shanghai Hengrui Pharmaceutical Co, Connect Biopharma, Pfizer, and others. DelveInsight's "Atopic Dermatitis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth
Affordable Roofing Systems: Tampa Roofing Company Prioritizes Emergency Roof Repairs Post-Hurricane Milton
Affordable Roofing Systems: Tampa Roofing Company Prioritizes Emergency Roof Rep …
Tampa, FL - In the wake of Hurricane Milton, which left over 500,000 customers without power in Hillsborough County alone and caused widespread roof damage in areas like St. Petersburg and Sarasota, Affordable Roofing Systems, Inc. [https://www.affordableroofingflorida.com/], a Tampa-based roofing contractor, is responding to the growing demand for emergency roof repairs. With more than 25 years of experience in Florida's weather challenges, the company has mobilized its team to provide
Cystinosis Market Expected to Experience Major Growth by 2034, According to DelveInsight | Horizon Pharma, Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharma, Nacuity Pharma, Avrobio
Cystinosis Market Expected to Experience Major Growth by 2034, According to Delv …
The Key Cystinosis Companies in the market include - Horizon Pharmaceutical/Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharmaceuticals, Inc., Nacuity Pharmaceuticals, Avrobio, and others. The Cystinosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Cystinosis pipeline products will significantly revolutionize the Cystinosis market dynamics. DelveInsight's "Cystinosis Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cystinosis, historical

All 5 Releases


More Releases for PetVivo

Aesthetic Injectables Market Report- Development, Trends, Industry Analysis, Siz …
Aesthetic Injectables Market research report provides region-wise and country-wise analyses of the Aesthetic Injectables Market. Additionally, Aesthetic Injectables Market provides insights about main regions like Asia-Pacific, Europe, North America, South America, Latin, Middle East, and Africa. Moreover, Aesthetic Injectables Market research report offers in-depth information about lucrative emerging markets and analyzes penetration across the significant market segments. Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4784575 Aesthetic Injectables Market Report provides
Minimally Invasive Surgical Devices Market Report- Size, Business Opportunities, …
The research report of the Minimally Invasive Surgical Devices Market provides a comprehensive overview of the market, size, and share. In addition, it provides the closest approximations of the revenue of the market and sub-segments across the different regions. The Minimally Invasive Surgical Devices Market research report is estimated to reach the highest CAGR. The Minimally Invasive Surgical Devices Market research report helps stakeholders understand the market pulse of the
Global Animal & Veterinary Medicine Market 2021 with Top Countries Data: Ongoing …
Big Market Research report entitled Global Animal Veterinary Medicine Market 2021-2026 by Manufacturers, Regions, Type and Application delivers extensive analysis of market trends and shares. The report interrogates the rudimentary factors of the market such as market overview, product classification, market demands, leading manufacturers, and various applications of the market, and growth scenario. The report provides invaluable insights into the players impacting the global Veterinary Pharmaceutical Drug market such as
Surgical Devices Market May Set Epic Growth Story with Aesculap, Colospan, Medtr …
Latest published market study on Surgical Devices (General Surgery) - Medical Devices Pipeline Product Landscape, 2021 Market provides an overview of the current market dynamics in the Surgical Devices (General Surgery) - Medical Devices Pipeline Product Landscape, 2021 space, as well as what our survey respondents—all outsourcing decision-makers—predict the market will look like in 2027. The study breaks market by revenue and volume (wherever applicable) and price history to estimates
Aesthetic Devices - Medical Devices Pipeline Assessment, 2020-2026 | Apex Medica …
A new market study is released on Aesthetic Devices - Medical Devices Pipeline Assessment, 2020 Market with data Tables for historical and forecast years represented with Chats & Graphs spread through 397 Pages with easy to understand detailed analysis. The study highlights detailed assessment of the Market and display market sizing trend by revenue & volume (if applicable), current growth factors, expert opinions, facts, and industry validated market development data.
Global Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessmen …
"The Report Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Coronary Artery Bypass Graft Surgery Market GlobalData's Medical Devices sector report, Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2017" provides an overview of Coronary Artery Bypass Graft Surgery currently in pipeline stage. Get Sample copy of this Report @